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Osteoarthritis (OA) is the most common form of arthritis and is among the leading causes of disability throughout the world 1 . Although many risk factors have been associated with OA, the pathogenesis of OA is still incompletely characterized. 2, 3 Inflammatory mechanisms play a crucial role in the pathogenesis and evolution of cartilage degredation. Recent studies have suggested that OA might be considered a chronic inflammatory disorder, and elevated levels of IL-1, tumor necrosis factor-, IL-6 and other acute phase proteins are found in patients with cartilage degradation. 4, 5 Among the cytokines, IL-1 is one of the most potent pro-inflammatory agents, and it seems to play an important role in signal transmission between cells of the tissue where inflammatory reactions occur. 6 IL-1 acts through its signalling receptor, IL-1 receptor type 1 (IL-1R1), and the degree of expression of this receptor influences the response of cells to IL-1. 7 Three structurally related ligands can bind to the IL-1 receptors: IL-1 and the more abundant IL-1 functioning as agonists, and IL-1 receptor antagonist (IL-1Ra) as an antagonist that results in no intracellular signalling. 8, 9 Genes encoding for cytokines have been associated with susceptibility for joint OA. Recent studies have indicated a role for the IL-1 gene cluster and the IL1RN gene in the development of OA of the hand, hip and knee. [10] [11] [12] We investigated the effect of polymorphisms in the IL1A, IL1B, and IL1RN genes in relation to the occurence of knee OA in Turkish patients.
Methods
Informed consent was obtained from each patient. The study was designed as an open, case-control trial and conducted according to the Declaration of Helsinki. All subjects were Caucasians from southern Turkey.
One hundred and seven patients with knee OA and 67 controls were included in this case control study. Diagnosis of knee OA was made according to the criteria of American College of Rheumatology. For assessment of cinical of the patients, the Turkish version of the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) was used. 13 All patients underwent anterior-posterior and lateral knee radiographs using standard procedures. Severity of radiographs was graded using the Kellgren and Lawrence scale (grade 1-4). Radiographs were assessed by one expert reader. In addition, venous blood samples were taken, and erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels were established.
Controls were enrolled from subjects admitted to the outpatient clinic of the physical therapy and rehabilitation department. Control subjects underwent clinical (criteria of American College of Rheumatology) and laboratory evaluations to exclude OA (hip, knee, hand, and vertebral) and other arthritis. The WOMAC index was not used and because their radiographs were normal, was not graded using the Kellgren and Lawrence scale. Control subjects had no relationship with cases and no family history of OA.
DNA extraction and analysis
Venous blood samples were collected in ethylenediaminetetraacetic acid (EDTA) containing tubes. DNA was extracted from whole blood by salting out procedure. 14 .
Genotypic Analysis of the IL1RN VNTR Polymorphism
Polymerase Chain Reaction (PCR) assays were used to determine IL1RN VNTR polymorphism in intron 2. The oligonucleotide primers used to determine the VNTR in intron 2 polymorphism within the IL1RN gene were described previously. 15, 16 The primers, forward 5'-CTCAGCAACACTCCTAT-3'; reverse 5'-TCCTGGTCTGCAGGTAA-3' were used to amplify of the IL1RN gene. PCR products of the IL1RN; Allel 1; 410 bp (four repeats), Allel 2; 240 bp (two repeats), Allel 3; 500 bp (five repeats), Allel 4; 325 bp (three repeats), Allel 5; 595 bp (six repeats).
Genotypic Analysis of the IL1B +3953 C T Polymorphism
Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) assay were used to determine IL1B +3953 C T polymorphism. The oligonucleotide primers used to determine the +3953 C T polymorphism within the IL1B gene were described previously 17 . The primers, forward 5'-GTTGTCATCAGACTTTGACC-3'; reverse 5'-TTCAGTTCATATGGACCAGA-3' were used to amplify of the IL1B gene. The Taq I restricted products of IL1B +3953, CC, CT and TT genotypes had band sizes of 135bp/114bp, 249bp/135bp/114bp and 249bp, respectively.
Genotypic Analysis of the IL1A +4845 C T Polymorphism
Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) assay were used to determine IL1A +4845 C T polymorphism. The oligonucleotide primers used to determine the +4845 C T polymorphism within the IL1A gene were described previously. 18 The primers, forward 5'-ATGGTTTTAGAAATCATCAAGCCTAGGGCA-3'; reverse 5'-AATGAAAGGAGGGGAGGATGACAGA AATGT-3' were used to amplify of the IL1A gene. All procedures were conducted blinded to the case status and other characteristics of the participants. Scoring of gels and data entry were conducted independently by two persons.
Statistical Analysis
The association between polymorphisms of the IL1RN, IL1A, IL1B genes and knee OA was tested using multiple logistic regression model. Odds ratios (ORs) for this model with the corresponding 95 % confidence intervals (95 % CIs) were computed. Allele frequencies were assessed by counting alleles and calculating sample proportions. The allelic frequency distributions in the control and OA groups were compared by the Pearson chi-squared test. In each group the allele distribution was checked for deviations from Hardy-Weinberg equilibrium using an exact test. The associations between genotypes of IL1B+3953, IL1A+4845 and IL1RN VNTR polymorphisms with clinical, laboratory and radiological characteristics of knee OA were investigated using one way ANOVA, Kruskal-Wallis and Pearson chi-squared tests. Statistical analyses were performed with SPSS software, version 12. Results were considered statistically significant when the probability of findings occurring by chance was less than 5% (P< 0.05).
Results
The demographic characteristics of the study population are shown in Table 1 . There were differences between groups in terms of age and BMI (P:0.0001) but no difference in terms of sex (P:0.569). The study population were adjusted for age (yr), and BMI (kg/ m ) using multiple logistic regression model. Thereafter, the genotypes distribution of IL1RN VNTR, IL1A+4845 and IL1B+3953 genes polymorphisms were compered between OA patients and the control group. There were no differences between groups (Table 2) .
Similarly, we detected no differences in allelic frequencies of IL1RN VNTR, IL1A+4845 and IL1B+3953 genes polymorphisms between the patients with knee OA and the controls ( Table 3) .
The relationships between genotypes of IL1RN VNTR, IL1A+4845 and IL1B+3953 genes polymorphisms and clinical characteristics (such as WOMAC pain, stiffness and physical function scores), laboratory measures (ESR, CRP), and K&L radiological 
Discussion
In the present study, three polymorphisms (VNTR in intron 2, +4845, and +3953 respectively) of the IL1RN, IL1A IL1B genes were assessed, genotypic and allelic frequencies were compared between patients and controls. No differences were found, which suggested that the IL1RN, IL1A, IL1B genes polymorphisms were not markers of genetic susceptibility to knee OA in Mersin. Furthermore, our study also suggested that IL1RN, IL1A, IL1B genes polymorphisms were unrelated to the clinical, radiological and laboratory characteristics of knee OA.
In contrast to our results, some researchers have suggested association between the IL-1 gene cluster and occurence of OA. analysis of genotype frequencies for the IL1B gene, more OA patients than controls were homozygous for allele 2, although any significant diffferences for the TNF-, IL1RN and IL-6 polymorphisms were found. 11 In the later study by Loughlin et al, seven single nucleotide polymorphisms (SNPs) and a VNTR polymorphism from within the IL-1 ligand genes IL1A (-889), IL1B (3954, 5810, -31, -511) and IL1RN (VNTR, 9589, 11100) were genotyped in knee or hip OA cases and controls. No association was detected with any of the variants. When they stratified their cases by site of disease (hip or knee), they detected a marginal association for SNP -889 in knee cases. 12 In contrast to Moos et al, there was no evidence for an association of this gene cluster to hip OA, which may reflect heterogenity of susceptibility between these different joint sites.
Recently, Meulenbelt et al, two polymorphisms of the IL1B gene (3953 and -511) and one polymorphism of the IL1RN gene (VNTR in intron 2) were assessed for the occurence of radiographic OA (ROA) of the hips, knees, hands, and disc dejeneration of the spine in a cohort. In contrast to results of Moos et al, a protective effect for hip ROA was observed in carriers of allele 2 of the 3953 polymorphism. Similar to Moos et al, a predisposing effect for hip ROA was observed in carriers of allele 2 of the -511 and VNTR polymorphisms. Moreover, when combining the risk alleles, an additive effect was observed in subjects carrying in creasing numbers of risk alleles of either the -511 or the VNTR polymorphism with a linear by linear association. 19 Much of our research has focused on individual polymorphisms or small numbers of polymorphisms in single genes. This approach may be oversimplistic due to the complex interaction of the ligands and receptors involved in the transduction an inhibition of IL-1 signalling. Smith et al. found no association between promoter haplotypes in the IL1R1 gene and knee OA but they identified an extended IL1A, IL1B, IL1RN risk haplotype (2C-CTG-1TT), which was more frequent in patients with knee OA. In an analysis of IL1B-IL1RN region haplotypes, one of these (CCA-1TT) was associated with a protective effect against knee OA. previous reports of linkage from some groups between markers in IL-1 region and OA in genome-wide-scans. OA is a complex genetic disease that is among the most difficult to analyze, due to its high frequency in the general population and its extensive clinical heterogeneity. The degree to which clinical heterogeneity translates into genetic heterogeneity is unknown. However, a number of epidemiological studies have highlighted potential differences in the degree of OA heritability between different joint groups. 21, 22 Recent studies support the approach of stratifying for site of disease when attempting to identify OA susceptibility genes. 12 Our study has some limitations. First, the size of the study population is small and our findings need to be confirmed with larger samples in Turkey. Second, in this study we did not make haplotype analysis of IL-1 gene cluster and this may be the reason for lack of association with knee OA. Recent reports have indicated that polymorphic IL-1 haplotypes, as opposed to single locus polymorphisms may provide better genetic markers of transcriptional activity and disease association. 20, 23 Another reason for the lack of association may be different effectively polymorphisms within IL-1 region on knee OA in Turkish patients. Finally, we cannot exclude evidence for an association of a haplotype within the IL-1 ligand gene cluster to knee OA. Further studies would be necessary to evaluate the real role of the polymorphic IL-1 haplotypes or extended haplotypes in Turkish patients with knee OA.
